January 8, 2021 Comments Off on New patent for Genus Lifesciences drug GOPRELTO Posted in: Patent Added Annual Drug Patent Expirations for GOPRELTO Goprelto is a drug marketed by Genus Lifesciences and is included in one NDA. There are six patents protecting this drug. Drug patent litigation…
The post New patent for Genus Lifesciences drug GOPRELTO appea…
January 8, 2021 Comments Off on New patent for Veloxis Pharms drug ENVARSUS XR Posted in: Patent Added Annual Drug Patent Expirations for ENVARSUS+XR Envarsus Xr is a drug marketed by Veloxis Pharms Inc and is included in one NDA. There are seventeen patents protecting this drug. Drug…
The post New patent for Veloxis Pharms drug ENVARSUS XR appeared fir…
